Harvey Norman lifts H1 profit

Retailer says property portfolio will continue to underpin its performance.

Harvey Norman (HVN) says its property portfolio will continue to underpin its performance in the years ahead, after posting a strong lift in first-half profit.

In the six months to December 31, the retailer posted a net profit of $111.42 million, a 36% increase on the $81.92m recorded in the first half of the previous year.

Excluding the effects of a net property revaluation decrement of $8.61m (compared to $44.97m in the previous period) net profit after tax for the half year was $117.45m, an increase of 3.6% on the previous period.

In the same period, revenue was $2.48 billion, a slight 1.4% lift on the $2.44bn posted in the previous corresponding period.

Global sales for the half year increased to $2.99 billion, a 3.6% increase from the previous corresponding period and a 4.9% increase on a like-for-like basis.

The group will pay a fully-franked interim dividend of 6c on May 5 to shareholders on the register at April 11.

Harvey Norman chairman Gerry Harvey said the group's property portfolio continues to underpin the business through the strength and stability it provides.

"We have more than doubled our net asset base in the last nine years and our property assets have provided a solid foundation to our integrated retail, franchising and property system for more than three decades," he said.

"To my mind, our ownership of real property is an absolute competitive strength when compared with the intangibles and goodwill that figure prominently on the balance sheets of many of our competitors."

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles